EXAGEN INC. - COMMON STOCK

Exagen Inc. Reports Second Quarter 2022 Results

04 8月 2022 15:05:01 条件 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference

25 7月 2022 15:05:00 条件 Nasdaq GlobeNewswire

Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022

21 7月 2022 15:05:00 条件 Nasdaq GlobeNewswire

Exagen Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility

05 7月 2022 07:25:00 条件 Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with MediNcrease

09 6月 2022 07:25:00 条件 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference

26 5月 2022 15:05:00 条件 Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus

16 5月 2022 15:05:00 条件 Nasdaq GlobeNewswire

Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test

11 5月 2022 15:06:00 条件 Nasdaq GlobeNewswire

Exagen Inc. Reports First Quarter 2022 Results

11 5月 2022 15:05:01 条件 Nasdaq GlobeNewswire

Exagen Announces Five-Week Campaign for Lupus Awareness Month

01 5月 2022 11:00:00 条件 Nasdaq GlobeNewswire

Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022

25 4月 2022 15:05:00 条件 Nasdaq GlobeNewswire

Exagen Inc. to Participate in Investor Summit Group’s Q2 Conference

20 4月 2022 15:05:00 条件 Nasdaq GlobeNewswire

Exagen Inc. Expands In-Network Access with Evolutions Healthcare Systems

30 3月 2022 07:25:00 条件 Nasdaq GlobeNewswire

Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives

22 3月 2022 15:06:00 条件 Nasdaq GlobeNewswire

Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results

22 3月 2022 15:05:00 条件 Nasdaq GlobeNewswire

Exagen Announces New Rheumatoid Arthritis Scientific Advisory Board

16 3月 2022 15:05:00 条件 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2022 KeyBanc Capital Markets Life Sciences and MedTech Investor Forum

09 3月 2022 15:05:00 条件 Nasdaq GlobeNewswire

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 22, 2022

08 3月 2022 15:05:00 条件 Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2022 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

02 2月 2022 15:05:00 条件 Nasdaq GlobeNewswire

Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection

09 1月 2022 11:00:00 条件 Nasdaq GlobeNewswire